PHAR

PHAR

USD

Pharming Group N.V. ADS each representing 10 ordinary shares

$11.140+0.090 (0.814%)

实时价格

Healthcare
生物技术
荷兰

价格图表

Loading Chart...

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$11.050

最高价

$11.140

最低价

$11.050

成交量

0.00M

公司基本面

市值

767.1M

所属行业

生物技术

国家/地区

Netherlands

交易统计

平均成交量

0.00M

交易所

NGM

货币

USD

52周价格范围

最低价 $6.65当前价 $11.140最高价 $12.61

相关新闻

GlobeNewswire

Pharming Group reports first quarter 2025 financial results and provides business update

First quarter 2025 total revenues increased by 42% to US$79.1 million, compared to the first quarter 2024 RUCONEST® revenue increased by 49% to US$68.6 million, compared to the first quarter 2024, reflecting

查看更多
Pharming Group reports first quarter 2025 financial results and provides business update
GlobeNewswire

Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)

Leiden, the Netherlands, April 25, 2025: Pharming Group N.V. ("Pharming" or "the Company") (NASDAQ:PHAR) announces the following presentations by the Company or its collaborators at the 2025 Annual Meeting of the

查看更多
Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)
GlobeNewswire

Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS

For media and investors only Joenja® is the first and only medicine specifically for APDS to be reimbursed within the NHS Recommended for adult and pediatric patients 12 years of age and older with activated

查看更多
Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS